ICD-10-CM E71.440 is the diagnosis code for Ruvalcaba-Myhre-Smith syndrome. This code falls under the section "Metabolic disorders" within Chapter 4 — Endocrine, nutritional and metabolic diseases (E00-E89). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where E71.440 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, E71.440 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
E71.440 is the ICD-10-CM diagnosis code for "Ruvalcaba-Myhre-Smith syndrome". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of E71.440 is E71.44 ("Other secondary carnitine deficiency"). E71.440 provides a more specific classification within this category.
E71.440 is located in Section E70-E88 — "Metabolic disorders" within Chapter 4 of the ICD-10-CM Tabular List.
Use E71.440 when the patients documented diagnosis matches "Ruvalcaba-Myhre-Smith syndrome" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Ruvalcaba-Myhre-Smith syndrome is E71.440.
Yes, E71.440 can be used as a primary diagnosis code since it is billable and specific.
E71.440 is in Chapter 4 of the ICD-10-CM Tabular List.
Yes, E71.440 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.